Prelude Therapeutics
(NASDAQ:PRLD)
$4.87
0.10[2.10%]
At close: Mar 27
$4.87
0[0.00%]
PreMarket: 4:56PM EDT
37.5%
Overview Rating
Speculative
Technicals Analysis
66
0100
Financials Analysis
20
0100

Prelude Therapeutics Stock (NASDAQ:PRLD), Quotes and News Summary

Prelude Therapeutics Stock (NASDAQ: PRLD) stock price, news, charts, stock research, profile.
Open-
Close-
Volume / Avg.0 / 73.223K
Day Range- - -
52 Wk Range1.660 - 8.565
Market Cap$267.463M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
62
Short Interest
3.79%
Days to Cover5.08
20%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
Oct 23
1
Nov 23
1
Dec 23
1
Feb
0
0
0
0
Mar
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
53.7
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell
About Prelude Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Prelude Therapeutics Incorp is a clinical-stage precision oncology company focused on discovering an...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
PRLD
BLUE

FAQ

Q

How do I buy Prelude Therapeutics (PRLD) stock?

A

You can purchase shares of Prelude Therapeutics (NASDAQ: PRLD) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Prelude Therapeutics's (PRLD) competitors?

Q

What is the target price for Prelude Therapeutics (PRLD) stock?

A

The latest price target for Prelude Therapeutics (NASDAQ: PRLD) was reported by JMP Securities on Wednesday, March 13, 2024. The analyst firm set a price target for 7.00 expecting PRLD to rise to within 12 months (a possible 43.74% upside). 8 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Prelude Therapeutics (PRLD)?

A

The stock price for Prelude Therapeutics (NASDAQ: PRLD) is $4.87 last updated March 27, 2024 at 4:56 PM EDT.

Q

Does Prelude Therapeutics (PRLD) pay a dividend?

A

There are no upcoming dividends for Prelude Therapeutics.

Q

When is Prelude Therapeutics (NASDAQ:PRLD) reporting earnings?

A

Prelude Therapeutics’s Q1 earnings are confirmed for Monday, May 6, 2024.

Q

Is Prelude Therapeutics (PRLD) going to split?

A

There is no upcoming split for Prelude Therapeutics.

Q

What sector and industry does Prelude Therapeutics (PRLD) operate in?

A

Prelude Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch